نتائج البحث

Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response.

• Authors : Xu S; Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, Guangdong, China. .; Zheng Y

Subjects: Receptor, EphB2*/Receptor, EphB2*/Receptor, EphB2*/genetics ; Receptor, EphB2*/Receptor, EphB2*/Receptor, EphB2*/metabolism ; Biomarkers, Tumor*/Biomarkers, Tumor*/Biomarkers, Tumor*/genetics

• Source: BMC cancer [BMC Cancer] 2024 Aug 28; Vol. 24 (1), pp. 1064. Date of Electronic Publication: 2024 Aug 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Comprehensive pan-cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance.

• Authors : Chen Q; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Breast Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

Subjects: Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Neoplasms*/Neoplasms*/Neoplasms*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

• Source: Clinical and translational medicine [Clin Transl Med] 2024 Jun; Vol. 14 (6), pp. e1735.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326

تفاصيل العنوان

Identifying cell type-specific transcription factor-mediated activity immune modules reveal implications for immunotherapy and molecular classification of pan-cancer.

• Authors : Li F; College of Bioinformatics Science and Technology, Harbin Medical University, 157 Baojian Road, Harbin, China.; Wang J

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

• Source: Briefings in bioinformatics [Brief Bioinform] 2024 Jul 25; Vol. 25 (5).Publisher: Oxford University Press Country of Publication: England NLM ID: 100912837 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication.

• Authors : Chen D; Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; Research Institute of Pancreatic Diseases, Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Subjects: Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Neoplasms*/Neoplasms*/Neoplasms*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

• Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Apr 25; Vol. 43 (1), pp. 125. Date ofPublisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

تفاصيل العنوان

The association of ROS1 mutation with cancer immunity and its impact on the efficacy of pan-cancer immunotherapy.

• Authors : Li Y; Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.; Second Affiliated Hospital, Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.

Subjects: Immunotherapy* ; Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/immunology

• Source: Journal of translational medicine [J Transl Med] 2024 Apr 30; Vol. 22 (1), pp. 403. Date of Electronic Publication: 2024 Apr 30.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy.

• Authors : Wang C; Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, 362000, China.; Li Y

Subjects: Mutation* ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Neoplasms*/Neoplasms*/Neoplasms*/genetics

• Source: Molecular cancer [Mol Cancer] 2024 Apr 25; Vol. 23 (1), pp. 81. Date of Electronic Publication: 2024 Apr 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

Spindle component 25 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis.

• Authors : Xia F; Department of Neurology of the First People's Hospital of Zhaoqing, China, Zhaoqing, 526000, China.; Yang H

Subjects: Immunotherapy* ; Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

• Source: Scientific reports [Sci Rep] 2024 Apr 11; Vol. 14 (1), pp. 8452. Date of Electronic Publication: 2024 Apr 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Pan-cancer integrative analyses dissect the remodeling of endothelial cells in human cancers.

• Authors : Li, Jinhu¹ (AUTHOR); Wang, Dongfang¹ (AUTHOR) ; Tang, Fei^1,2 (AUTHOR)

• Source: National Science Review. Sep2024, Vol. 11 Issue 9, p1-16. 16p.

تفاصيل العنوان

Comprehensive analysis of PILRΑ's association with the prognosis, tumor immune infiltration, and immunotherapy in pan-cancer.

• Authors : Li Q; Department of Pathology, People's Hospital of Deyang City, Deyang, China.; Yang Z

Subjects: Immunotherapy* ; Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

• Source: Scientific reports [Sci Rep] 2023 Aug 31; Vol. 13 (1), pp. 14334. Date of Electronic Publication: 2023 Aug 31.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Comprehensive analysis to identify IL7R as a immunotherapy biomarker from pan-cancer analysis to in vitro validation

• Authors : Jiafeng Liang; Lucheng Zhu; Jiawei Li

Subjects: Immunotherapy; Pan-cancer; Tumor microenvironment

• Source: Discover Oncology, Vol 15, Iss 1, Pp 1-17 (2024)

تفاصيل العنوان